STEPHANIE MEYERS: Open Payments
NPI 1346088770 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$970 in 44 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $241 · 2025 $970
Food & beverage: $970
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $211 |
| AstraZeneca Pharmaceuticals LP | 5 | $166 |
| Viatris Specialty LLC | 4 | $86 |
| Exact Sciences Corporation | 4 | $69 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Amgen Inc. | 3 | $44 |
| Astellas Pharma US Inc | 2 | $38 |
| Abbott Laboratories | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
Products named: UBRELVY, BREZTRI, YUPELRI, Cologuard Collection Kit, OTEZLA, AIRSUPRA, Veozah, FREESTYLE LIBRE 3.
Industry payments across AZ — which companies pay providers there.
